var eventsData = [{"Ticker":"AVGO","EffectiveDate":"2016-12-14","Type":"Dividend","Title":"The Firm pays dividend $1.02","DailyReturn":-0.004484,"FiveDayReturnAfter":0.020251,"FiveDayReturnBefore":0.08535},{"Ticker":"AVGO","EffectiveDate":"2016-12-08","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2016 Q4's earning $3.47 per share and revenue $4146MM. This beats analyst's estimated EPS $3.38, beats estimated revenue $4120MM.","DailyReturn":0.012815,"FiveDayReturnAfter":0.058114,"FiveDayReturnBefore":-0.011445},{"Ticker":"AVGO","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Loop Capital initiates coverage on AVGO to Buy. Target Price is $206.","DailyReturn":-0.008247,"FiveDayReturnAfter":0.06991,"FiveDayReturnBefore":-0.050012},{"Ticker":"AVGO","EffectiveDate":"2016-11-03","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Overweight.","DailyReturn":0.002492,"FiveDayReturnAfter":0.004972,"FiveDayReturnBefore":-0.002546},{"Ticker":"AVGO","EffectiveDate":"2016-10-06","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on AVGO to Market Perform.","DailyReturn":0.004093,"FiveDayReturnAfter":-0.017502,"FiveDayReturnBefore":0.016155},{"Ticker":"AVGO","EffectiveDate":"2016-10-05","Type":"RatingNeutral","Title":"Bernstein initiates coverage on AVGO to Outperform. Target Price is $215.","DailyReturn":0.026205,"FiveDayReturnAfter":0.012463,"FiveDayReturnBefore":-0.010649},{"Ticker":"AVGO","EffectiveDate":"2016-10-04","Type":"RatingNeutral","Title":"Bernstein initiates coverage on AVGO to Outperform. Target Price is $215.","DailyReturn":-0.005998,"FiveDayReturnAfter":0.027261,"FiveDayReturnBefore":0.020075},{"Ticker":"AVGO","EffectiveDate":"2016-09-20","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on AVGO to Positive.","DailyReturn":-0.014643,"FiveDayReturnAfter":-0.023947,"FiveDayReturnBefore":0.040305},{"Ticker":"AVGO","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $180; previously $200.","DailyReturn":0.021407,"FiveDayReturnAfter":0.004308,"FiveDayReturnBefore":0.004194},{"Ticker":"AVGO","EffectiveDate":"2016-09-15","Type":"Dividend","Title":"The Firm pays dividend $0.51","DailyReturn":0.021407,"FiveDayReturnAfter":0.004308,"FiveDayReturnBefore":0.004194},{"Ticker":"AVGO","EffectiveDate":"2016-09-06","Type":"RatingNeutral","Title":"Argus Research maintains AVGO to Buy. Target Price is $195; previously $184.","DailyReturn":-0.011611,"FiveDayReturnAfter":-0.051138,"FiveDayReturnBefore":-0.023125},{"Ticker":"AVGO","EffectiveDate":"2016-09-02","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $205; previously $185.","DailyReturn":-0.022474,"FiveDayReturnAfter":-0.09662,"FiveDayReturnBefore":0.005947},{"Ticker":"AVGO","EffectiveDate":"2016-09-01","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2016 Q3's earning $2.89 per share and revenue $3802MM. This beats analyst's estimated EPS $2.77, beats estimated revenue $3760MM.","DailyReturn":0.003798,"FiveDayReturnAfter":-0.046643,"FiveDayReturnBefore":0.006368},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Citigroup assumes AVGO to Buy. Target Price is $205.","DailyReturn":-0.002255,"FiveDayReturnAfter":-0.036158,"FiveDayReturnBefore":0.008321},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $200; previously $180.","DailyReturn":-0.002255,"FiveDayReturnAfter":-0.036158,"FiveDayReturnBefore":0.008321},{"Ticker":"AVGO","EffectiveDate":"2016-08-30","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $185.","DailyReturn":-0.002255,"FiveDayReturnAfter":-0.036158,"FiveDayReturnBefore":0.008321},{"Ticker":"AVGO","EffectiveDate":"2016-08-12","Type":"RatingNeutral","Title":"Baird initiates coverage on AVGO to Outperform.","DailyReturn":0.002208,"FiveDayReturnAfter":0.010634,"FiveDayReturnBefore":0.030085},{"Ticker":"AVGO","EffectiveDate":"2016-06-15","Type":"Dividend","Title":"The Firm pays dividend $0.5","DailyReturn":-0.000568,"FiveDayReturnAfter":-0.017055,"FiveDayReturnBefore":-0.036135},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $191; previously $182.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"RBC Capital maintains AVGO to Top Pick. Target Price is $185; previously $180.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"B. Riley maintains AVGO to Buy. Target Price is $200; previously $190.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains AVGO to Buy. Target Price is $211; previously $189.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $180; previously $170.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $185; previously $170.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $200; previously $180.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Buy. Target Price is $190; previously $180.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $190; previously $180.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $185; previously $171.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Cowen & Co. maintains AVGO to Outperform. Target Price is $200; previously $190.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains AVGO to Buy. Target Price is $200; previously $185.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-03","Type":"RatingNeutral","Title":"Craig-Hallum maintains AVGO to Buy. Target Price is $200; previously $190.","DailyReturn":0.049383,"FiveDayReturnAfter":0.057874,"FiveDayReturnBefore":0.008689},{"Ticker":"AVGO","EffectiveDate":"2016-06-02","Type":"EarningsRelease","Title":"After market close, AVGO reports 2016 Q2's earning $2.53 per share and revenue $3562MM..","DailyReturn":0.000905,"FiveDayReturnAfter":0.056095,"FiveDayReturnBefore":0.021883},{"Ticker":"AVGO","EffectiveDate":"2016-05-17","Type":"RatingNeutral","Title":"CLSA initiates coverage on AVGO to Outperform. Target Price is $165.","DailyReturn":-0.010375,"FiveDayReturnAfter":0.037494,"FiveDayReturnBefore":0.001756},{"Ticker":"AVGO","EffectiveDate":"2016-05-02","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $171; previously $175.","DailyReturn":0.002264,"FiveDayReturnAfter":-0.02684,"FiveDayReturnBefore":-0.030942},{"Ticker":"AVGO","EffectiveDate":"2016-04-18","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on AVGO to Outperform.","DailyReturn":0.002637,"FiveDayReturnAfter":-0.033747,"FiveDayReturnBefore":-0.004236},{"Ticker":"AVGO","EffectiveDate":"2016-03-16","Type":"Dividend","Title":"The Firm pays dividend $0.49","DailyReturn":0.004393,"FiveDayReturnAfter":0.0448,"FiveDayReturnBefore":0.061389},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Overweight. Target Price is $175; previously $170.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"FBR Capital maintains AVGO to Outperform. Target Price is $185; previously $180.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $180; previously $157.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $162; previously $160.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $175; previously $155.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $200; previously $175.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $180; previously $160.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $182; previously $180.","DailyReturn":0.063569,"FiveDayReturnAfter":0.050339,"FiveDayReturnBefore":0.03603},{"Ticker":"AVGO","EffectiveDate":"2016-02-26","Type":"RatingNeutral","Title":"B. Riley initiates coverage on AVGO to Buy. Target Price is $175.","DailyReturn":0.004831,"FiveDayReturnAfter":0.03603,"FiveDayReturnBefore":0.041618},{"Ticker":"AVGO","EffectiveDate":"2016-02-24","Type":"RatingNeutral","Title":"Sidoti & Co. maintains AVGO to Buy. Target Price is $168; previously $180.","DailyReturn":0.01701,"FiveDayReturnAfter":0.077085,"FiveDayReturnBefore":0.015094},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Credit Suisse assumes AVGO to Outperform. Target Price is $160.","DailyReturn":0.037646,"FiveDayReturnAfter":0.071214,"FiveDayReturnBefore":-0.053608},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingNeutral","Title":"Topeka initiates coverage on AVGO to Hold.","DailyReturn":0.037646,"FiveDayReturnAfter":0.071214,"FiveDayReturnBefore":-0.053608},{"Ticker":"AVGO","EffectiveDate":"2016-02-16","Type":"RatingUpgrade","Title":"JP Morgan upgrades AVGO to Overweight from Neutral. Target Price is $170.","DailyReturn":0.037646,"FiveDayReturnAfter":0.071214,"FiveDayReturnBefore":-0.053608},{"Ticker":"AVGO","EffectiveDate":"2016-02-03","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on AVGO to Buy.","DailyReturn":-0.01411,"FiveDayReturnAfter":-0.107078,"FiveDayReturnBefore":0.068731},{"Ticker":"AVGO","EffectiveDate":"2016-02-02","Type":"RatingNeutral","Title":"Barclays initiates coverage on AVGO to Overweight. Target Price is $170.","DailyReturn":-0.032249,"FiveDayReturnAfter":-0.122058,"FiveDayReturnBefore":0.100708},{"Ticker":"AVGO","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on AVGO to Buy.","DailyReturn":0.015246,"FiveDayReturnAfter":0.009846,"FiveDayReturnBefore":-0.077826},{"Ticker":"AVGO","EffectiveDate":"2015-12-21","Type":"RatingUpgrade","Title":"RBC Capital upgrades AVGO to Top Pick from Outperform.","DailyReturn":0.039943,"FiveDayReturnAfter":0.04293,"FiveDayReturnBefore":-0.02658},{"Ticker":"AVGO","EffectiveDate":"2015-12-16","Type":"Dividend","Title":"The Firm pays dividend $0.44","DailyReturn":0.007351,"FiveDayReturnAfter":0.015767,"FiveDayReturnBefore":-0.030993},{"Ticker":"AVGO","EffectiveDate":"2015-12-03","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $180; previously $170.","DailyReturn":0.095076,"FiveDayReturnAfter":0.096816,"FiveDayReturnBefore":0.029709},{"Ticker":"AVGO","EffectiveDate":"2015-12-01","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on AVGO to Positive. Target Price is $160.","DailyReturn":0.018705,"FiveDayReturnAfter":0.131816,"FiveDayReturnBefore":0.031538},{"Ticker":"AVGO","EffectiveDate":"2015-11-10","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on AVGO to Buy. Target Price is $156.","DailyReturn":-0.05249,"FiveDayReturnAfter":-0.040575,"FiveDayReturnBefore":0.021574},{"Ticker":"AVGO","EffectiveDate":"2015-09-16","Type":"Dividend","Title":"The Firm pays dividend $0.42","DailyReturn":-0.018438,"FiveDayReturnAfter":-0.071629,"FiveDayReturnBefore":0.039619},{"Ticker":"AVGO","EffectiveDate":"2015-09-10","Type":"RatingUpgrade","Title":"JMP Securities upgrades AVGO to Market Outperform from Market Perform. Target Price is $165.","DailyReturn":0.012188,"FiveDayReturnAfter":0.036536,"FiveDayReturnBefore":0.063297},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $159; previously $160.","DailyReturn":0.086575,"FiveDayReturnAfter":0.065292,"FiveDayReturnBefore":-0.04419},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $170; previously $180.","DailyReturn":0.086575,"FiveDayReturnAfter":0.065292,"FiveDayReturnBefore":-0.04419},{"Ticker":"AVGO","EffectiveDate":"2015-08-27","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Buy. Target Price is $180; previously $179.","DailyReturn":0.086575,"FiveDayReturnAfter":0.065292,"FiveDayReturnBefore":-0.04419},{"Ticker":"AVGO","EffectiveDate":"2015-08-26","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2015 Q3's earning $2.24 per share and revenue $1750MM. This beats analyst's estimated EPS $2.14, beats estimated revenue $1740MM.","DailyReturn":0.070869,"FiveDayReturnAfter":0.095386,"FiveDayReturnBefore":-0.119144},{"Ticker":"AVGO","EffectiveDate":"2015-08-25","Type":"RatingUpgrade","Title":"CLSA upgrades AVGO to Buy from Outperform. Target Price is $150.","DailyReturn":-0.013007,"FiveDayReturnAfter":0.136109,"FiveDayReturnBefore":-0.13253},{"Ticker":"AVGO","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $165; previously $170.","DailyReturn":0.005274,"FiveDayReturnAfter":-0.020914,"FiveDayReturnBefore":-0.026339},{"Ticker":"AVGO","EffectiveDate":"2015-07-16","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on AVGO to Outperform. Target Price is $185.","DailyReturn":0.022624,"FiveDayReturnAfter":-0.016303,"FiveDayReturnBefore":0.028257},{"Ticker":"AVGO","EffectiveDate":"2015-06-24","Type":"RatingNeutral","Title":"Argus Research initiates coverage on AVGO to Buy. Target Price is $163.","DailyReturn":-0.01179,"FiveDayReturnAfter":-0.063465,"FiveDayReturnBefore":0.000354},{"Ticker":"AVGO","EffectiveDate":"2015-06-17","Type":"Dividend","Title":"The Firm pays dividend $0.4","DailyReturn":-0.006356,"FiveDayReturnAfter":0.000354,"FiveDayReturnBefore":0.012615},{"Ticker":"AVGO","EffectiveDate":"2015-06-02","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on AVGO to Buy. Target Price is $180.","DailyReturn":-0.016778,"FiveDayReturnAfter":-0.056036,"FiveDayReturnBefore":0.100205},{"Ticker":"AVGO","EffectiveDate":"2015-05-29","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Overweight. Target Price is $180; previously $135.","DailyReturn":0.039963,"FiveDayReturnAfter":-0.008322,"FiveDayReturnBefore":0.097835},{"Ticker":"AVGO","EffectiveDate":"2015-05-29","Type":"RatingUpgrade","Title":"Jefferies upgrades AVGO to Buy from Hold. Target Price is $179; previously $125.","DailyReturn":0.039963,"FiveDayReturnAfter":-0.008322,"FiveDayReturnBefore":0.097835},{"Ticker":"AVGO","EffectiveDate":"2015-05-22","Type":"RatingNeutral","Title":"Mizuho initiates coverage on AVGO to Buy. Target Price is $150.","DailyReturn":0.023536,"FiveDayReturnAfter":0.133309,"FiveDayReturnBefore":0.02066},{"Ticker":"AVGO","EffectiveDate":"2015-05-12","Type":"RatingNeutral","Title":"Barclays assumes AVGO to Overweight. Target Price is $145.","DailyReturn":0.00114,"FiveDayReturnAfter":0.058279,"FiveDayReturnBefore":0.013526},{"Ticker":"AVGO","EffectiveDate":"2015-03-24","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $160; previously $131.","DailyReturn":-0.009819,"FiveDayReturnAfter":-0.029364,"FiveDayReturnBefore":0.037531},{"Ticker":"AVGO","EffectiveDate":"2015-03-23","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $160; previously $131.","DailyReturn":0.008628,"FiveDayReturnAfter":-0.038859,"FiveDayReturnBefore":0.06716},{"Ticker":"AVGO","EffectiveDate":"2015-03-18","Type":"Dividend","Title":"The Firm pays dividend $0.38","DailyReturn":0.013362,"FiveDayReturnAfter":0.03361,"FiveDayReturnBefore":0.031314},{"Ticker":"AVGO","EffectiveDate":"2015-03-16","Type":"RatingUpgrade","Title":"DA Davidson upgrades AVGO to Buy from Neutral. Target Price is $150; previously $125.","DailyReturn":0.03896,"FiveDayReturnAfter":0.06716,"FiveDayReturnBefore":-0.022856},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $135; previously $115.","DailyReturn":0.147054,"FiveDayReturnAfter":0.138357,"FiveDayReturnBefore":0.024072},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $131; previously $110.","DailyReturn":0.147054,"FiveDayReturnAfter":0.138357,"FiveDayReturnBefore":0.024072},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Neutral. Target Price is $130; previously $110.","DailyReturn":0.147054,"FiveDayReturnAfter":0.138357,"FiveDayReturnBefore":0.024072},{"Ticker":"AVGO","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $130; previously $105.","DailyReturn":0.147054,"FiveDayReturnAfter":0.138357,"FiveDayReturnBefore":0.024072},{"Ticker":"AVGO","EffectiveDate":"2015-02-25","Type":"EarningsBeatRevenueMiss","Title":"After market close, AVGO reports 2015 Q1's earning $2.09 per share and revenue $1635MM. This beats analyst's estimated EPS $1.93, misses estimated revenue $1640MM.","DailyReturn":-0.004418,"FiveDayReturnAfter":0.124768,"FiveDayReturnBefore":0.020622},{"Ticker":"AVGO","EffectiveDate":"2014-12-17","Type":"Dividend","Title":"The Firm pays dividend $0.35","DailyReturn":0.020726,"FiveDayReturnAfter":0.038435,"FiveDayReturnBefore":-0.05312},{"Ticker":"AVGO","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $115; previously $108.","DailyReturn":0.013098,"FiveDayReturnAfter":0.00098,"FiveDayReturnBefore":0.042398},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $110; previously $105.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $115; previously $100.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Bank of America maintains AVGO to Buy. Target Price is $118; previously $100.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Jefferies maintains AVGO to Hold. Target Price is $104; previously $84.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $100; previously $84.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $120; previously $105.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $125; previously $105.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $110; previously $96.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $120; previously $100.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-04","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $108; previously $100.","DailyReturn":0.083465,"FiveDayReturnAfter":0.042398,"FiveDayReturnBefore":0.042739},{"Ticker":"AVGO","EffectiveDate":"2014-12-03","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q4's earning $1.99 per share and revenue $1610MM. This beats analyst's estimated EPS $1.68, beats estimated revenue $1550MM.","DailyReturn":0.031779,"FiveDayReturnAfter":0.107268,"FiveDayReturnBefore":0.011565},{"Ticker":"AVGO","EffectiveDate":"2014-12-02","Type":"RatingNeutral","Title":"Brean Capital maintains AVGO to Buy. Target Price is $105; previously $87.","DailyReturn":0.013744,"FiveDayReturnAfter":0.101935,"FiveDayReturnBefore":0.008171},{"Ticker":"AVGO","EffectiveDate":"2014-11-25","Type":"RatingNeutral","Title":"Morgan Stanley maintains AVGO to Overweight. Target Price is $96; previously $90.","DailyReturn":0.00011,"FiveDayReturnAfter":0.011565,"FiveDayReturnBefore":0.029167},{"Ticker":"AVGO","EffectiveDate":"2014-10-16","Type":"RatingUpgrade","Title":"Brean Capital upgrades AVGO to Buy from Hold. Target Price is $87.","DailyReturn":0.04204,"FiveDayReturnAfter":0.108444,"FiveDayReturnBefore":-0.138173},{"Ticker":"AVGO","EffectiveDate":"2014-10-06","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $97; previously $95.","DailyReturn":-0.007068,"FiveDayReturnAfter":-0.156749,"FiveDayReturnBefore":-0.047152},{"Ticker":"AVGO","EffectiveDate":"2014-09-30","Type":"RatingNeutral","Title":"Nomura maintains AVGO. Target Price is $95; previously $85.","DailyReturn":-0.001263,"FiveDayReturnAfter":-0.049778,"FiveDayReturnBefore":-0.000803},{"Ticker":"AVGO","EffectiveDate":"2014-09-17","Type":"Dividend","Title":"The Firm pays dividend $0.32","DailyReturn":0.001598,"FiveDayReturnAfter":-0.000457,"FiveDayReturnBefore":-0.005557},{"Ticker":"AVGO","EffectiveDate":"2014-09-09","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $100; previously $90.","DailyReturn":0.002495,"FiveDayReturnAfter":-0.016924,"FiveDayReturnBefore":0.07168},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"MKM Partners maintains AVGO to Buy. Target Price is $88; previously $84.","DailyReturn":0.075039,"FiveDayReturnAfter":0.140515,"FiveDayReturnBefore":0.00118},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $90; previously $80.","DailyReturn":0.075039,"FiveDayReturnAfter":0.140515,"FiveDayReturnBefore":0.00118},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Oppenheimer maintains AVGO to Outperform. Target Price is $100; previously $85.","DailyReturn":0.075039,"FiveDayReturnAfter":0.140515,"FiveDayReturnBefore":0.00118},{"Ticker":"AVGO","EffectiveDate":"2014-08-29","Type":"RatingNeutral","Title":"Credit Suisse maintains AVGO to Outperform. Target Price is $105; previously $75.","DailyReturn":0.075039,"FiveDayReturnAfter":0.140515,"FiveDayReturnBefore":0.00118},{"Ticker":"AVGO","EffectiveDate":"2014-08-28","Type":"EarningsBeatRevenueMiss","Title":"After market close, AVGO reports 2014 Q3's earning $1.26 per share and revenue $1270MM. This beats analyst's estimated EPS $1.05, misses estimated revenue $1350MM.","DailyReturn":0.002626,"FiveDayReturnAfter":0.122559,"FiveDayReturnBefore":-0.002884},{"Ticker":"AVGO","EffectiveDate":"2014-07-14","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $90; previously $46.","DailyReturn":0.011475,"FiveDayReturnAfter":0.024292,"FiveDayReturnBefore":-0.02669},{"Ticker":"AVGO","EffectiveDate":"2014-06-17","Type":"Dividend","Title":"The Firm pays dividend $0.29","DailyReturn":0.012608,"FiveDayReturnAfter":0.009166,"FiveDayReturnBefore":-0.012757},{"Ticker":"AVGO","EffectiveDate":"2014-05-30","Type":"RatingNeutral","Title":"Raymond James maintains AVGO to Outperform. Target Price is $83; previously $65.","DailyReturn":-0.001695,"FiveDayReturnAfter":0.015141,"FiveDayReturnBefore":0.034199},{"Ticker":"AVGO","EffectiveDate":"2014-05-29","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q2's earning $0.85 per share and revenue $701MM. This beats analyst's estimated EPS $0.76, beats estimated revenue $679.59MM.","DailyReturn":0.009843,"FiveDayReturnAfter":0.021312,"FiveDayReturnBefore":0.037499},{"Ticker":"AVGO","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on AVGO to Buy. Target Price is $80.","DailyReturn":-0.003636,"FiveDayReturnAfter":-0.0182,"FiveDayReturnBefore":0.020868},{"Ticker":"AVGO","EffectiveDate":"2014-05-13","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $75; previously $70.","DailyReturn":-0.005352,"FiveDayReturnAfter":-0.011787,"FiveDayReturnBefore":0.073206},{"Ticker":"AVGO","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"Barclays initiates coverage on AVGO to Overweight. Target Price is $85.","DailyReturn":-0.007947,"FiveDayReturnAfter":-0.000295,"FiveDayReturnBefore":0.067889},{"Ticker":"AVGO","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"Pacific Crest maintains AVGO to Outperform from Outperform. Target Price is $85; previously $85.","DailyReturn":-0.007947,"FiveDayReturnAfter":-0.000295,"FiveDayReturnBefore":0.067889},{"Ticker":"AVGO","EffectiveDate":"2014-04-07","Type":"RatingNeutral","Title":"Goldman Sachs maintains AVGO to Buy. Target Price is $70; previously $66.","DailyReturn":-0.023301,"FiveDayReturnAfter":-0.054365,"FiveDayReturnBefore":-0.036698},{"Ticker":"AVGO","EffectiveDate":"2014-03-28","Type":"RatingNeutral","Title":"Pacific Crest initiates coverage on AVGO to Outperform. Target Price is $75.","DailyReturn":0.021185,"FiveDayReturnAfter":0.018152,"FiveDayReturnBefore":-0.039509},{"Ticker":"AVGO","EffectiveDate":"2014-03-18","Type":"Dividend","Title":"The Firm pays dividend $0.27","DailyReturn":0.01077,"FiveDayReturnAfter":0.000317,"FiveDayReturnBefore":0.009667},{"Ticker":"AVGO","EffectiveDate":"2014-02-25","Type":"RatingNeutral","Title":"Raymond James initiates coverage on AVGO to Outperform. Target Price is $65.","DailyReturn":-0.009569,"FiveDayReturnAfter":0.035779,"FiveDayReturnBefore":0.025332},{"Ticker":"AVGO","EffectiveDate":"2014-02-25","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2014 Q1's earning $0.84 per share and revenue $709MM. This beats analyst's estimated EPS $0.78, beats estimated revenue $705.29MM.","DailyReturn":-0.009569,"FiveDayReturnAfter":0.035779,"FiveDayReturnBefore":0.025332},{"Ticker":"AVGO","EffectiveDate":"2014-02-14","Type":"RatingNeutral","Title":"DA Davidson downgrades AVGO to Neutral from Buy. Target Price is $64; previously $60.","DailyReturn":-0.016926,"FiveDayReturnAfter":-0.00901,"FiveDayReturnBefore":0.067929},{"Ticker":"AVGO","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"JMP Securities downgrades AVGO to Market Perform from Market Outperform.","DailyReturn":0.002375,"FiveDayReturnAfter":0.001018,"FiveDayReturnBefore":0.087906},{"Ticker":"AVGO","EffectiveDate":"2014-02-12","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $70; previously $60.","DailyReturn":0.014982,"FiveDayReturnAfter":-0.006391,"FiveDayReturnBefore":0.07248},{"Ticker":"AVGO","EffectiveDate":"2013-12-18","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":-0.003001,"FiveDayReturnAfter":-0.013027,"FiveDayReturnBefore":0.139203},{"Ticker":"AVGO","EffectiveDate":"2013-12-17","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $60; previously $46.","DailyReturn":0.069062,"FiveDayReturnAfter":0.043055,"FiveDayReturnBefore":0.056032},{"Ticker":"AVGO","EffectiveDate":"2013-12-16","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Buy. Target Price is $60; previously $55.","DailyReturn":0.097481,"FiveDayReturnAfter":0.128166,"FiveDayReturnBefore":-0.028293},{"Ticker":"AVGO","EffectiveDate":"2013-12-12","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on AVGO to Outperform. Target Price is $60.","DailyReturn":-0.007807,"FiveDayReturnAfter":0.146768,"FiveDayReturnBefore":0.03554},{"Ticker":"AVGO","EffectiveDate":"2013-12-04","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Neutral. Target Price is $46; previously $40.","DailyReturn":-0.006253,"FiveDayReturnAfter":0.039838,"FiveDayReturnBefore":0.024183},{"Ticker":"AVGO","EffectiveDate":"2013-12-02","Type":"RatingUpgrade","Title":"DA Davidson upgrades AVGO to Buy from Neutral. Target Price is $55; previously $41.","DailyReturn":0.006036,"FiveDayReturnAfter":0.048651,"FiveDayReturnBefore":0.03828},{"Ticker":"AVGO","EffectiveDate":"2013-11-12","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on AVGO to Buy. Target Price is $53.","DailyReturn":0.02081,"FiveDayReturnAfter":-0.00567,"FiveDayReturnBefore":-0.0186},{"Ticker":"AVGO","EffectiveDate":"2013-10-18","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades AVGO to Conviction Buy from Buy. Target Price is $54; previously $48.","DailyReturn":0.021286,"FiveDayReturnAfter":0.008611,"FiveDayReturnBefore":0.035892},{"Ticker":"AVGO","EffectiveDate":"2013-10-03","Type":"RatingNeutral","Title":"Charter Equity downgrades AVGO to Buy from Strong Buy.","DailyReturn":-0.002534,"FiveDayReturnAfter":-0.02827,"FiveDayReturnBefore":0.028033},{"Ticker":"AVGO","EffectiveDate":"2013-09-17","Type":"Dividend","Title":"The Firm pays dividend $0.23","DailyReturn":0.027401,"FiveDayReturnAfter":0.069727,"FiveDayReturnBefore":0.013067},{"Ticker":"AVGO","EffectiveDate":"2013-09-17","Type":"RatingUpgrade","Title":"JMP Securities upgrades AVGO to Market Outperform from Market Perform. Target Price is $55.","DailyReturn":0.027401,"FiveDayReturnAfter":0.069727,"FiveDayReturnBefore":0.013067},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $45; previously $43.","DailyReturn":0.047332,"FiveDayReturnAfter":0.064368,"FiveDayReturnBefore":-0.006544},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"Nomura maintains AVGO to Buy. Target Price is $42; previously $40.","DailyReturn":0.047332,"FiveDayReturnAfter":0.064368,"FiveDayReturnBefore":-0.006544},{"Ticker":"AVGO","EffectiveDate":"2013-08-28","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $41; previously $39.","DailyReturn":0.047332,"FiveDayReturnAfter":0.064368,"FiveDayReturnBefore":-0.006544},{"Ticker":"AVGO","EffectiveDate":"2013-08-27","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on AVGO to Market Perform.","DailyReturn":-0.024813,"FiveDayReturnAfter":0.022947,"FiveDayReturnBefore":0.033369},{"Ticker":"AVGO","EffectiveDate":"2013-08-27","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2013 Q3's earning $0.74 per share and revenue $644MM. This beats analyst's estimated EPS $0.61, beats estimated revenue $622.78MM.","DailyReturn":-0.024813,"FiveDayReturnAfter":0.022947,"FiveDayReturnBefore":0.033369},{"Ticker":"AVGO","EffectiveDate":"2013-08-15","Type":"RatingNeutral","Title":"Brean Capital downgrades AVGO to Hold from Buy; previously $43.","DailyReturn":-0.032241,"FiveDayReturnAfter":-0.017071,"FiveDayReturnBefore":-0.001881},{"Ticker":"AVGO","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Citigroup downgrades AVGO to Neutral from Buy.","DailyReturn":0.000271,"FiveDayReturnAfter":-0.005708,"FiveDayReturnBefore":-0.053567},{"Ticker":"AVGO","EffectiveDate":"2013-07-11","Type":"RatingNeutral","Title":"Jefferies downgrades AVGO to Hold from Buy. Target Price is $42.","DailyReturn":0.006783,"FiveDayReturnAfter":0.015275,"FiveDayReturnBefore":-0.003906},{"Ticker":"AVGO","EffectiveDate":"2013-07-02","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on AVGO to Overweight. Target Price is $45.","DailyReturn":0.023132,"FiveDayReturnAfter":-0.000797,"FiveDayReturnBefore":0.024766},{"Ticker":"AVGO","EffectiveDate":"2013-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.21","DailyReturn":0.037462,"FiveDayReturnAfter":0.062317,"FiveDayReturnBefore":-0.027956},{"Ticker":"AVGO","EffectiveDate":"2013-05-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains AVGO to Buy. Target Price is $45; previously $40.","DailyReturn":0.098461,"FiveDayReturnAfter":0.07199,"FiveDayReturnBefore":-0.018986},{"Ticker":"AVGO","EffectiveDate":"2013-05-29","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2013 Q2's earning $0.61 per share and revenue $562MM. This beats analyst's estimated EPS $0.53, beats estimated revenue $557.78MM.","DailyReturn":-0.00029,"FiveDayReturnAfter":0.093091,"FiveDayReturnBefore":0.000001},{"Ticker":"AVGO","EffectiveDate":"2013-03-21","Type":"Dividend","Title":"The Firm pays dividend $0.19","DailyReturn":-0.005036,"FiveDayReturnAfter":-0.002803,"FiveDayReturnBefore":-0.001669},{"Ticker":"AVGO","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $37; previously $38.","DailyReturn":0.016903,"FiveDayReturnAfter":0.035581,"FiveDayReturnBefore":-0.07022},{"Ticker":"AVGO","EffectiveDate":"2013-02-26","Type":"EarningBeat","Title":"After market close, AVGO reports 2013 Q1's earning $0.65 per share and revenue $576MM. This beats analyst's estimated EPS $0.55, meets estimated revenue $576MM.","DailyReturn":0.005463,"FiveDayReturnAfter":0.017748,"FiveDayReturnBefore":-0.064349},{"Ticker":"AVGO","EffectiveDate":"2013-01-09","Type":"RatingNeutral","Title":"Topeka initiates coverage on AVGO to Buy. Target Price is $40.","DailyReturn":0.022118,"FiveDayReturnAfter":0.053674,"FiveDayReturnBefore":0.014118},{"Ticker":"AVGO","EffectiveDate":"2012-12-13","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades AVGO to Buy from Neutral. Target Price is $44; previously $40.","DailyReturn":-0.020349,"FiveDayReturnAfter":-0.072633,"FiveDayReturnBefore":0.001158},{"Ticker":"AVGO","EffectiveDate":"2012-12-13","Type":"Dividend","Title":"The Firm pays dividend $0.17","DailyReturn":-0.020349,"FiveDayReturnAfter":-0.072633,"FiveDayReturnBefore":0.001158},{"Ticker":"AVGO","EffectiveDate":"2012-11-30","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $38.","DailyReturn":0.0,"FiveDayReturnAfter":0.000571,"FiveDayReturnBefore":0.067163},{"Ticker":"AVGO","EffectiveDate":"2012-11-29","Type":"EarningsMissRevenueBeat","Title":"AVGO reports 2012 Q4's earning $0.64 per share and revenue $618MM. This misses analyst's estimated EPS $0.67, beats estimated revenue $614.98MM.","DailyReturn":0.015625,"FiveDayReturnAfter":-0.000868,"FiveDayReturnBefore":0.051964},{"Ticker":"AVGO","EffectiveDate":"2012-11-27","Type":"RatingNeutral","Title":"DA Davidson maintains AVGO to Neutral. Target Price is $38.","DailyReturn":0.00235,"FiveDayReturnAfter":0.022369,"FiveDayReturnBefore":0.063677},{"Ticker":"AVGO","EffectiveDate":"2012-11-05","Type":"RatingNeutral","Title":"DA Davidson downgrades AVGO to Neutral from Buy.","DailyReturn":0.010303,"FiveDayReturnAfter":-0.01453,"FiveDayReturnBefore":0.037186},{"Ticker":"AVGO","EffectiveDate":"2012-10-03","Type":"RatingNeutral","Title":"Capstone initiates coverage on AVGO to Buy. Target Price is $40.","DailyReturn":0.004358,"FiveDayReturnAfter":-0.024409,"FiveDayReturnBefore":0.041829},{"Ticker":"AVGO","EffectiveDate":"2012-09-18","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":0.001139,"FiveDayReturnAfter":-0.014918,"FiveDayReturnBefore":0.007967},{"Ticker":"AVGO","EffectiveDate":"2012-09-04","Type":"RatingNeutral","Title":"Barclays maintains AVGO to Overweight. Target Price is $40; previously $43.","DailyReturn":-0.018594,"FiveDayReturnAfter":-0.043879,"FiveDayReturnBefore":0.014321},{"Ticker":"AVGO","EffectiveDate":"2012-08-17","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $43; previously $42.","DailyReturn":-0.001896,"FiveDayReturnAfter":-0.024408,"FiveDayReturnBefore":-0.011046},{"Ticker":"AVGO","EffectiveDate":"2012-08-17","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AVGO to Buy. Target Price is $43; previously $42.","DailyReturn":-0.001896,"FiveDayReturnAfter":-0.024408,"FiveDayReturnBefore":-0.011046},{"Ticker":"AVGO","EffectiveDate":"2012-08-16","Type":"EarningsRevenueBeat","Title":"After market close, AVGO reports 2012 Q3's earning $0.72 per share and revenue $606MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $600.74MM.","DailyReturn":0.009021,"FiveDayReturnAfter":-0.002463,"FiveDayReturnBefore":-0.024305},{"Ticker":"AVGO","EffectiveDate":"2012-08-14","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $45; previously $39.","DailyReturn":-0.003309,"FiveDayReturnAfter":-0.008583,"FiveDayReturnBefore":-0.021816},{"Ticker":"AVGO","EffectiveDate":"2012-08-13","Type":"RatingNeutral","Title":"UBS initiates coverage on AVGO to Buy. Target Price is $43.","DailyReturn":-0.023688,"FiveDayReturnAfter":-0.008379,"FiveDayReturnBefore":0.001078},{"Ticker":"AVGO","EffectiveDate":"2012-08-02","Type":"RatingNeutral","Title":"Goldman Sachs initiates coverage on AVGO to Neutral. Target Price is $40.","DailyReturn":-0.004088,"FiveDayReturnAfter":0.021304,"FiveDayReturnBefore":0.069987},{"Ticker":"AVGO","EffectiveDate":"2012-07-24","Type":"RatingNeutral","Title":"Canaccord Genuity initiates coverage on AVGO to Buy. Target Price is $42.","DailyReturn":-0.008988,"FiveDayReturnAfter":0.042017,"FiveDayReturnBefore":0.052071},{"Ticker":"AVGO","EffectiveDate":"2012-06-14","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":-0.017114,"FiveDayReturnAfter":0.039915,"FiveDayReturnBefore":0.03194},{"Ticker":"AVGO","EffectiveDate":"2012-05-23","Type":"RatingNeutral","Title":"JP Morgan maintains AVGO to Neutral. Target Price is $32; previously $33.","DailyReturn":0.071954,"FiveDayReturnAfter":0.055666,"FiveDayReturnBefore":0.007061},{"Ticker":"AVGO","EffectiveDate":"2012-05-16","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $39; previously $44.","DailyReturn":-0.009018,"FiveDayReturnAfter":0.007061,"FiveDayReturnBefore":-0.015975},{"Ticker":"AVGO","EffectiveDate":"2012-03-15","Type":"Dividend","Title":"The Firm pays dividend $0.13","DailyReturn":0.021092,"FiveDayReturnAfter":0.036639,"FiveDayReturnBefore":0.037336},{"Ticker":"AVGO","EffectiveDate":"2012-02-23","Type":"RatingNeutral","Title":"Citigroup maintains AVGO to Buy. Target Price is $44; previously $43.","DailyReturn":0.035933,"FiveDayReturnAfter":0.046533,"FiveDayReturnBefore":0.039489}];